Remifentanil hydrochloride
Drug ingredientActive ShortageCAS 132539-07-2
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293333 · basket
These shares come from HS customs code 293333, which covers 11 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- India
- Brazil
- Latvia
8 FDA-registered drug labelers
Why It Matters
Appears in 2 drug and cosmetic product listings (FDA).
- •Remifentanil Hydrochloride
- •Ultiva
- Current shortage
Remifentanil Hydrochloride Injection
Shortage listed since June 28, 2022
Manufacturer reports: 1 unavailable, 1 available
Chemical Identity
Data Sources
- PubChem · compound 60814Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Remifentanil hydrochloride (CAS 132539-07-2) https://chemicalindependence.com/chemical/132539-07-2/ PubChem: 60814. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/60814 FDA National Drug Code directory: CAS 132539-07-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 132539-07-2. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293333 for CAS 132539-07-2. Reporting year: 2024. https://usatrade.census.gov/